Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award
Lynn M. Schuchter, MD, FASCO
University of Pennsylvania
International Women Who Conquer Cancer Mentorship Award
Verna Vanderpuye, MBChB
National Center for Radiotherapy, Oncology and Nuclear Medicine at Korlebu Teaching Hospital, Ghana
Lynn M. Schuchter, MD, FASCO, is the C. Willard Robinson Professor of Hematology-Oncology at the University of Pennsylvania, chief of the Division of Hematology-Oncology, and program leader for the Melanoma and Cutaneous Malignancies Program at the Abramson Cancer Center of the University of Pennsylvania. Dr. Schuchter’s clinical and clinical research focuses on melanoma, with particular interest in novel therapies for advanced disease. Dr. Schuchter has a strong commitment to and passion for mentorship, especially women. She has shown by example and through her leadership to promote and pave the way for women at Penn and for women and men in oncology.
Verna Vanderpuye, MBChB, is a senior consultant at the National Center for Radiotherapy, Oncology and Nuclear Medicine at Korlebu Teaching Hospital, Ghana, affiliated with the University of Ghana, Accra. Her interests are in breast, sarcoma, genitourinary, and gastrointestinal cancers and cancer management in Africa. She is the pioneer female oncologist in the West African region, and has mentored many regional and international young cancer professionals from their training through mid-career. Her holistic, whole-patient philosophy has resulted in improved quality of life even in the face of limited resources, at the same time prompting research opportunities and developing cost-effective, pragmatic approaches to the implementation of new evidence.
Women Who Conquer Cancer Tribute Award
Arti Hurria, MD, FASCO
City of Hope
The oncology community lost a dedicated researcher and mentor when Arti Hurria, MD, FASCO, died on November 7, 2018. Dr. Hurria was the George Tsai Family Chair in Geriatric Oncology, director of the Center on Cancer and Aging, co-lead of the Cancer Control and Population Sciences Program, vice provost of clinical faculty, a professor in the Department of Medical Oncology & Therapeutics Research, and a medical oncologist at City of Hope. She was a member of the ASCO Board of Directors and a donor and volunteer to ASCO’s Conquer Cancer Foundation. In recognition of Dr. Hurria’s legacy of mentorship, her indelible contributions to the field of geriatric oncology, and her passion for supporting women in cancer research, Conquer Cancer honors Dr. Hurria with a special Women Who Conquer Cancer Tribute Award.
The WWCC Mentorship Award Selection Group would also like to extend special congratulations to all of the 2019 nominees:
Smita Bhatia, MD, MPH, FASCO, University of Alabama At Birmingham School of Medicine
Susan K. Boolbol, MD, Beth Israel Medical Center
Deborah Bruner, RN, PhD, FAAN, Emory University
Suzanne Cole, MD, FACP, UT Southwestern Medical Center
Nancy E. Davidson, MD, FASCO, Fred Hutchinson Cancer Research Center
Mary L. Disis, MD, FASCO, University of Washington
S. Gail Eckhardt, MD, FASCO, University of Texas at Austin Dell Medical School
Cathy Eng, MD, FACP, FASCO, University of Texas MD Anderson Cancer Center
Lakesha Nicole Farmer, West Cancer Center
Arlene A. Forastiere, MD, FASCO, Johns Hopkins University School of Medicine
Silvia Formenti, MD, NewYork-Presbyterian/Weill Cornell Medical Center
Janice Lynn Gabrilove, MD, The Mt Sinai School of Medicine
Patricia A. Ganz, MD, FASCO, University of California Los Angeles Schools of Medicine and Public Health
Sharon H. Giordano, MD, MPH, FASCO, University of Texas MD Anderson Cancer Center
Lucy A. Godley, MD, PhD, University of Chicago
Julie Gralow, MD, FASCO, Seattle Cancer Care Alliance
Melissa M. Hudson, MD, FASCO, St. Jude Children's Research Hospital
Kelly Hunt, MD, University of Texas MD Anderson Cancer Center
Salma Jabbour, MD, Cancer Institute of New Jersey Robert Wood Johnson University Hospital
Michelle Christine Janelsins, PhD, MPH, University of Rochester Medical Center
Lisa A. Kachnic, MD, Vanderbilt University
Kim Kramer, MD, Memorial Sloan Kettering Cancer Center
Christine Laronga, MD, H. Lee Moffitt Cancer Center and Research Institute
Michelle M. Le Beau, PhD, University of Chicago
Nancy U. Lin, MD, Dana-Farber Cancer Institute
Nita Jane Maihle, PhD, Medical College of Georgia
Funda Meric-Bernstam, MD, University of Texas MD Anderson Cancer Center
Shannon R. Morris, MD, PhD, G1 Therapeutics
Monica Morrow, MD, FASCO, Memorial Sloan Kettering Cancer Center
Beverly Moy, MD, FASCO, Massachusetts General Hospital
Therese Marie Mulvey, MD, FASCO, Massachusetts General Hospital Cancer Center
Barbara A. Murphy, MD, Vanderbilt University
Tatiana Michelle Prowell, MD, US Food and Drug Administration
Carolyn D. Runowicz, MD, FASCO, Herbert Wertheim College of Medicine - Florida International University
Kathleen M. Schmeler, MD, University of Texas MD Anderson Cancer Center
Lecia V. Sequist, MD, MPH, Massachusetts General Hospital
Sandy Srinivas, MD, Stanford Medical Center
Nancy Tarbell, MD, Harvard Medical School
Jennifer S. Temel, MD, Massachusetts General Hospital
Elizabeth Travis, University of Texas MD Anderson Cancer Center
Lori J. Wirth, MD, Massachusetts General Hospital
Wendy A. Woodward, MD, PhD, University of Texas MD Anderson Cancer Center
Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award
Lori J. Pierce, MD, FASTRO, FASCO
University of Michigan School of Medicine
Lori J. Pierce, MD, FASTRO, FASCO, is a professor with tenure of radiation oncology and vice provost for academic and faculty affairs at the University of Michigan School of Medicine. Her research focuses on the use of radiotherapy in the multimodality treatment of breast cancer with emphasis on cardiac-sparing in treatment planning, pre-clinical and clinical studies of radiation sensitizers with radiation therapy, and outcomes following radiation in women with breast cancer who carry a BRCA1/2 susceptibility gene. Dr. Pierce was an ASCO Board of Directors member from 2010 to 2014. She is currently chair of the Conquer Cancer Foundation Nominating Committee and past chair of the ASCO Leadership Development Program.
International Women Who Conquer Cancer Mentorship Award
Rejin Kebudi, MD
Istanbul University, Cerrahpasa Faculty of Medicine and Istanbul University, Oncology Institute
Rejin Kebudi, MD, is a professor in pediatric hematology-oncology at the Istanbul University, Cerrahpasa Faculty of Medicine and the Istanbul University, Oncology Institute. She served on the board of the Istanbul University, Oncology Institute and as the director of the Pediatric Hematology-Oncology Division. She is a past president of the Turkish Pediatric Oncology Group and current chair of the International Society of Pediatric Oncology Supportive Care Working Group. She has been actively involved in the scientific activities of the Middle East Cancer Consortium. Dr. Kebudi has successfully mentored residents, fellows, and junior faculty over the last 25 years and has ensured that they make progress in their career.
Elizabeth Shpall, MD
University of Texas MD Anderson Cancer Center
Elizabeth Shpall, MD, is Medical Director of the Cell Therapy Laboratory, Director of the Cord Blood Bank and Deputy Chair of the Department of Stem Cell Transplantation and Cellular Therapy at The University of Texas M.D. Anderson Cancer Center. Dr. Shpall has more than 25 years of experience performing stem cell transplants and translating stem cell graft manipulations from the laboratory to the clinic. She has had continuous RO1 funding from the National Cancer Institute for the past 18 years, and lead a recently funded PO1 on improving cord blood transplantation focusing recently on the ex vivo expansion of umbilical cord blood in allogeneic mesenchymal stem cell co-cultures. She received a CPRIT High Risk/High Reward grant for the development of cord blood-derived Natural Killer (NK) cells, and a CLL Alliance grant to evaluate cord blood-NK cells in CLL patients. Dr. Shpall is the immediate past president of the American Society of Blood and Marrow Transplantation (ASBMT) and vice president of Netcord. Having served as the founding president for the Foundation of Accreditation of Cellular Therapy and as past president of ASBMT, Dr. Shpall has successfully mentored residents, post-doctoral fellows, and junior faculty over the last 25 years and has ensured that mentees are able to establish their own clinical and/or research niches.
Mary Gospodarowicz, MD, FRCR, FRCPC
University of Toronto, Princess Margaret Cancer Centre, and Cancer Care Ontario
Mary K. Gospodarowicz, MD, is the medical director at Princess Margaret Cancer Centre and regional vice president of Cancer Care Ontario. She recently served as president for the Union for International Cancer Control (UICC). Dr. Gospodarowicz’s research interests focus on the role of radiation therapy in lymphomas, prostate cancer, bladder cancer, and testis cancer clinical trials. Her numerous mentees describe her as a committed, compassionate, strong advocate for female professionals who leads by example.
Mary Gospodarowicz is Professor of Radiation Oncology at the University of Toronto, the Medical Director of the Princess Margaret Cancer Centre at the University Health Network, and the Regional Vice President of Cancer Care Ontario. She is past Chair of Radiation Oncology at the University of Toronto. She holds specialty certifications in internal medicine, radiation oncology, and medical oncology and her clinical practice involves lymphomas and genitourinary cancers. Her research focused on clinical trials evaluating radiation therapy, image-guided precision radiotherapy, and cancer survivorship. Her current interests include global cancer control, global access to radiotherapy, and quality cancer care. Her numerous mentees describe her as a committed, compassionate, strong advocate for female professionals who leads by example.
Professor Gospodarowicz is Past-President of the Union for International Cancer Control (UICC). She proudly participates in the work of the Global Task Force on Cancer Care and Control of Harvard Global Equity Initiative and the HGEI-Lancet Commission on Global Access to Pain Control & Palliative Care. Under the auspices of UICC and Lancet Oncology, the Global Task Force on Radiotherapy produced a seminal report on ‘Expanding the global access to radiotherapy” that provided evidence for the demand, efficacy, and cost effectiveness of radiotherapy.
Sarah S. Donaldson, MD, FASCO
An esteemed faculty member since 1973 and the unofficial "heart and soul of radiation oncology" at Stanford University School of Medicine, Dr. Donaldson is perhaps most widely known for her decades-long research and contributions related to improving quality of treatment and of life for children with cancer. Yet, it is her unwavering dedication to mentorship that distinguishes her as the utmost role model to young women oncologists today. Dr. Donaldson is the Catharine and Howard Avery Professor in the Department of Radiation Oncology at Stanford University School of Medicine, as well as the Associate Director of the residency program at Stanford's Department of Radiation Oncology and Chief of the Radiation Oncology service at the Packard Children's Hospital in Stanford, California.
Dr. Donaldson is a woman of truly remarkable achievement and has consistently paved the way for women in oncology for nearly half a century. She attended Dartmouth Medical School as one of only six women in a class of 48 students. She was the first female president of the American Board of Radiology and of the American Society for Therapeutic Radiology and Oncology (ASTRO). She was the first female radiation oncologist to serve as president of the Radiological Society of North America. She has served on the ASCO and Conquer Cancer Boards of Directors, and is a member of the National Academy of Medicine/Institute of Medicine. Still, current and former colleagues name her role as mentor among the most defining of her illustrious career.